GSK’s Velzatinib Obtains Orphan Drug Designation in Japan for GIST
GSK said velzatinib obtained orphan drug designation in Japan for gastrointestinal stromal tumor treatment.
GSK said velzatinib obtained orphan drug designation in Japan for gastrointestinal stromal tumor treatment.